openPR Logo
Press release

Artificial Intelligence (AI) in HIV/AIDS Market Developments and Future Forecasts in the Healthcare Sector

12-03-2024 07:17 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Ai In Hiv/Aids Market

Ai In Hiv/Aids Market

The artificial intelligence (AI) in HIV/AIDS market size was valued at USD 245.39 million in 2021. It is projected to grow to USD 519.63 million by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2022 to 2030.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐Ÿ๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
The use of advanced computational technologies in HIV/AIDS, known as artificial intelligence (AI), aims to enhance the knowledge, diagnosis, treatment, and prevention of HIV/AIDS. AI is capable of examining extensive datasets, recognizing trends in patient results, enhancing drug development, forecasting disease advancement, and aiding in customized treatment strategies. It also helps in public health initiatives by improving early identification, surveillance, and allocation of resources to better address the spread of HIV/AIDS.

๐†๐ž๐ญ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐š๐ ๐ž๐ฌ ๐จ๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-ai-in-hiv-aids-market/request-for-sample

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ:
โ€ข Researchers around the world increasingly rely on this advanced technology to identify the best sequence of medical cocktails, which are combinations of medications for patients.
โ€ข The AI in HIV/AIDS market is expected to grow due to the implementation of virtual reality tools for HIV zero disclosure and developed intelligence-powered chatbots for HIV/AIDS education.

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:
Because there are so many companies in the market, it is expected to be both competitive and fragmented. Here is the list of the leading companies operating in the artificial intelligence (AI) in HIV/AIDS market:
โ€ข Amazon Web Services,
โ€ข General Electric Healthcare,
โ€ข General Vision Inc.,
โ€ข Google Inc.,
โ€ข IBM,
โ€ข Intel Corporation,
โ€ข Johnson & Johnson Services Inc.,
โ€ข Koninklijke Philips N.V.,
โ€ข Medtronic plc,
โ€ข Microsoft Corporation,
โ€ข NVIDIA Corporation
โ€ข Siemens Healthineers AG.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐š ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž: https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-ai-in-hiv-aids-market/request-for-discount-pricing

๐†๐ž๐จ๐ ๐ซ๐š๐ฉ๐ก๐ข๐œ๐š๐ฅ ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž:
In 2021, North America dominated the global AI in the HIV/AIDS industry, holding the largest market share. This significant share is primarily attributed to the presence of major industry players in the United States and a growing emphasis on leveraging artificial intelligence solutions. The region's high adoption rate of AI technologies, combined with substantial healthcare spending, is expected to further propel industry growth in North America.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:
The artificial intelligence (AI) in HIV/AIDS market is primarily segmented on the basis of data, tools, region, and types of algorithms. Based on tools analysis, in 2021, the machine learning segment accounted for the largest market share and is anticipated to lead the market in the projection period. A significant portion of the sector's success is due to using this technology to find possible PrEP candidates in healthcare facilities in the US, Denmark, and Eastern Africa.

๐๐ฒ ๐“๐จ๐จ๐ฅ๐ฌ
โ€ข Machine Learning
โ€ข Natural Language Processing
โ€ข Image Processing
โ€ข Speech Recognition
โ€ข Others

๐๐ฒ ๐ƒ๐š๐ญ๐š
โ€ข Patient Data
โ€ข Insurance Information
โ€ข Hospital Stay

๐๐ฒ ๐“๐ฒ๐ฉ๐ž๐ฌ ๐จ๐Ÿ ๐€๐ฅ๐ ๐จ๐ซ๐ข๐ญ๐ก๐ฆ๐ฌ
โ€ข Artificial Neural Networks
โ€ข Deep Learning
โ€ข Others

๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐ฆ๐จ๐ซ๐ž ๐š๐›๐จ๐ฎ๐ญ ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž:
https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-ai-in-hiv-aids-market/inquire-before-buying

๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
๐Œ๐ฎ๐ฅ๐ญ๐ข๐จ๐ฆ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/multiomics-market

๐•๐จ๐ข๐œ๐ž ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐ข๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/voice-technology-in-healthcare-market

๐‚๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ฅ๐ฅ๐ง๐ž๐ฌ๐ฌ ๐ˆ๐ง๐ฌ๐ฎ๐ซ๐š๐ง๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/critical-illness-insurance-market

๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐’๐š๐Ÿ๐ž๐ญ๐ฒ ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ ๐š๐ง๐ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/biologics-safety-testing-market

๐•๐ข๐ญ๐š๐ฆ๐ข๐ง ๐ƒ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/vitamin-d-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence (AI) in HIV/AIDS Market Developments and Future Forecasts in the Healthcare Sector here

News-ID: 3767701 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โ€ฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโ€ฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โ€ฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected toโ€ฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โ€ฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโ€ฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โ€ฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโ€ฆ

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri โ€ฆ
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,โ€ฆ
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is โ€ฆ
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence ofโ€ฆ
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re โ€ฆ
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplicationโ€ฆ
HIV Therapeutics Marketโ€“ South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africaโ€™s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drugโ€™s resistance. The company has launched Aspen Stavudine which was its first generic ARVโ€ฆ
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction โ€ฆ
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific waysโ€ฆ